Global Branded Generics Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

In 2022, Aurobindo strikes Branded Generics buyout to build biosimilars 'launch pad' in India

• Pharmaceutical drugs that are chemically identical to their original brand-name counterparts but marketed under other labels are known as branded generics. They are produced by multiple businesses after the original drug's patent expires. Branded generics are less expensive alternatives that provide the same quality and efficacy as the original product.
• Off-invoice discounts are frequently offered by pharmaceutical companies to encourage bulk purchases by distributors or pharmacies. This practice increases demand for branded generics by making them cheaper to healthcare providers and patients, hence encouraging market growth.
• As the worldwide obesity epidemic worsens, so will the demand for lipid-lowering drugs. Branded generics in this therapeutic area appeal to cost-conscious consumers looking for effective therapies, promoting market expansion.
• The rising prevalence of chronic diseases and cancer, combined with an ageing population, results in increased healthcare needs. Branded generics gain popularity due to their cost-effectiveness in managing chronic illnesses, which boosts market demand.
• When patents on original branded drugs expire, generic producers have an opportunity to make and market equivalent equivalents at reduced prices. This encourages the use of branded generics, luring patients and healthcare systems looking to cut expenses.
• Favorable generic medicine approval and market entry legislation and policies simplify the process for branded generics. A favorable regulatory environment encourages firms to invest in these products, propelling the branded generics market forward.
• Due to expanding middle-class populations, increased healthcare knowledge, and rising demand for cheap drugs, emerging nations present considerable prospects for branded generics. These markets provide pharmaceutical businesses with unexplored opportunities to develop their branded generics portfolio and get a larger market share.
• Developing markets frequently offer a favorable environment for branded generics, with favorable policies and regulations encouraging generic drug manufacture and distribution. This offers an appealing environment for pharmaceutical companies to launch branded generic goods and gain a competitive advantage.
• Pharmaceutical businesses continue to spend in branded generics research and development (R&D). These investments result in the creation of new formulations, delivery systems, and therapeutic combinations, which improve the efficacy and commercial appeal of branded generics. R&D initiatives also assist businesses in differentiating their products and establishing a strong market presence.
• However, Risk Evaluation and Mitigation Strategies (REMS) for branded generics may be overly or incorrectly implemented in some situations. This could result in unnecessary market access restrictions, delaying product availability and affecting the potential growth of branded generics.
• Payers, such as government healthcare programs and insurance firms, are putting increasing pressure on pharmaceutical prices in order to keep healthcare expenditures under control. This price pressure might limit branded generics' pricing flexibility, reducing profit margins and perhaps impeding market acceptance by healthcare providers and patients.
• Limited penetration of associated generic drugs refers to the difficulty that certain generic medications face in achieving market acceptability, even after the brand-name drugs' patents expire. This constraint gets worse by factors such as a lack of therapeutic equivalence perception or insufficient marketing activities.

Market Segmentations

• The Global Branded Generics Market is segmented based on Product, Application, Distribution Channel, and Geography.
• By Product, the Global Branded Generics Market is classified into Trade Named Generics, and Value-Added.
• Trade Named Generics hold a larger market share. Trade Named Generics are the same as brand-name pharmaceuticals but are marketed under various names, whereas Value-Added Generics include additional features.
• By Application, the Global Branded Generics Market is classified into Anti-Cancer, Anti-Infective, Cardiovascular, CNS, and Others.
• Anti-Cancer holds a larger market share. This is due to the increasing prevalence of cancer globally. The growing need for efficient and affordable oncology treatments drives Anti-Cancer drug market expansion.
• By Distribution Channel, the Global Branded Generics Market is classified into Hospital Pharmacy, Pharmacy, and Others.
• Hospital Pharmacy hold a larger market share. The high demand for pharmaceuticals in hospital settings, which is driven by inpatient and outpatient care requirements.
• By Geography, the Global Branded Generics Market is classified into the Americas, Europe, Middle-East & Africa, and Asia-Pacific.
• The Americas hold a larger market share. Due to factors such as a well-established healthcare infrastructure, more healthcare spending, and a huge patient population.

Recent Development

• Dr Reddy’s forays into trade generics in Indian market with RGenX - Jun 2023
• Hetero buys Johnson & Johnson’s plant in Telangana for ₹130 crore - October 2022

Company Profiles

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxemburg, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle-East and Africa (Egypt, Israel, Qatar, Nigeria, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

Ansoff Analysis

• The report presents a detailed Ansoff matrix analysis for the Global Branded Generics Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
• The publisher analyses the Global Branded Generics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
• Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Branded Generics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.
• Excel data sheet for the market size will also be provided with the report.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
• The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors
• The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.

Report Highlights:

• A complete analysis of the market, including the parent industry
• Important market dynamics and trends
• Impact Analysis - a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment.
• Market segmentation
• Competitive Analysis: Comparative analysis of competitor
• Historical, current, and projected size of the market based on value and volume
• Market size of the US states
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market